MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Prepaid & other currentassets$1,179,972 Accounts receivable$3,976 Restricted cash$20,000 Cash$409,000 Investment in gmp bio at fairvalue$22,653,225 Goodwill, net ofimpairment$2,788,230 In process r&d$1,101,760 Total current assets$1,612,948 Total assets$28,156,163 Total liabilities andstockholders equity$28,156,163 Total stockholdersequity$8,076,500 Total liabilities$20,079,663 Non-controlling interests-$974,078 Total oncotelictherapeutics, inc....$9,050,578 Total currentliabilities$20,079,663 Accumulated deficit-$39,108,893 Additional paid-in capital$43,765,008 Convertible debt-RelatedParty$3,542,244 Convertibledebt-Nonrelated Party$10,328,100 Derivative liability onnotes$670,844 Contingent consideration$2,625,000 Accounts payable -related party-Related...$347,598 Accounts payable andaccrued liabilities$2,565,877 Common stock, .01 parvalue 750,000,000...$4,394,463
Balance Sheet
source: myfinsight.com

Oncotelic Therapeutics, Inc. (OTLC)

Oncotelic Therapeutics, Inc. (OTLC)